This topic contains a solution. Click here to go to the answer

Author Question: The purpose of RS in the shunt clipper is A) current limiting B) peak limiting C) charge-time ... (Read 157 times)

fasfsadfdsfa

  • Hero Member
  • *****
  • Posts: 554
The purpose of RS in the shunt clipper is
 
  A) current limiting B) peak limiting
  C) charge-time limiting D) Vr reduction

Question 2

Which statement is true?
 
  A) A reverse-biased pn junction has minimum depletion layer width.
  B) A forward-biased pn junction has minimum depletion layer width.
  C) A forward-biased pn junction has maximum depletion layer width.
  D) None of the above



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

guyanai

  • Sr. Member
  • ****
  • Posts: 349
Answer to Question 1

A

Answer to Question 2

B




fasfsadfdsfa

  • Member
  • Posts: 554
Reply 2 on: Jul 28, 2018
Thanks for the timely response, appreciate it


mcabuhat

  • Member
  • Posts: 344
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

In the United States, there is a birth every 8 seconds, according to the U.S. Census Bureau's Population Clock.

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

More than 34,000 trademarked medication names and more than 10,000 generic medication names are in use in the United States.

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library